Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pacific Biosciences of California, Inc. (PACB) had Return on Equity of -349.72% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$37.18M |
|
$-8.28M |
|
$24.34M |
|
$12.84M |
|
$45.53M |
|
$-8.36M |
|
$0.27M |
|
$-8.09M |
|
$-8.09M |
|
$-8.28M |
|
$-8.28M |
|
$-8.28M |
|
$-8.28M |
|
$-8.36M |
|
$-4.58M |
|
305.82M |
|
305.82M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$369.52M |
|
$24.38M |
|
$412.85M |
|
$782.37M |
|
$65.36M |
|
-- |
|
$714.64M |
|
$780.00M |
|
$2.37M |
|
$-329.50M |
|
$2.37M |
|
310.49M |
|
| Cash Flow Statement Financials | |
$-44.69M |
|
$35.86M |
|
$1.44M |
|
$65.26M |
|
$57.86M |
|
$-7.39M |
|
$4.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
34.54% |
|
-22.48% |
|
-22.48% |
|
-- |
|
-21.76% |
|
-22.26% |
|
$2.27M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.48 |
|
1.27 |
|
71.05 |
|
|
Return on Equity |
-349.72% |
2.51% |
|
-1.06% |
|
-349.75% |
|
$0.01 |
|
$0.01 |
|
$-0.15 |
|